Telehealth-Delivered Cognitive Behavioral Therapy for Insomnia in Individuals with Multiple Sclerosis: A Pilot Study

Background. Over 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person cognitive behavioral therapy for insomnia (F2F-CBTi) is currently the first-line treatment for insomnia. However, given potential limitations to acce...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Multiple sclerosis international Jg. 2022; S. 1 - 8
Hauptverfasser: Turkowitch, David, Ludwig, Rebecca, Nelson, Eryen, Drerup, Michelle, Siengsukon, Catherine F.
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Egypt Hindawi 02.03.2022
John Wiley & Sons, Inc
Schlagworte:
ISSN:2090-2654, 2090-2662
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Abstract Background. Over 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person cognitive behavioral therapy for insomnia (F2F-CBTi) is currently the first-line treatment for insomnia. However, given potential limitations to access including mobility difficulty, fatigue, or living in a rural area, telehealth-delivered CBT-I (tele-CBTi) has been considered as an alternative treatment. The purpose of this study was to assess the feasibility and treatment effect of tele-CBTi in people with MS and compare it to outcomes from a F2F-CBTi study in individuals with MS. Methods. 11 individuals with MS and symptoms of insomnia participated in 6 weekly CBT-I sessions with a trained CBT-I provider via live video. Insomnia severity (ISI), sleep quality (PSQI), and fatigue severity (FSS and MFIS) were assessed pre- and posttreatment as primary outcomes. Sleep onset latency (SOL), sleep efficiency (SE) and total sleep time (TST) from the PSQI, depression (PHQ-9), anxiety (GAD-7), sleep self-efficacy (SSES), and quality of life (MSIS-29) were also assessed pre- and posttreatment as secondary outcomes. Results. Participants resided in 9 different states. Retention and adherence rates were 100%. There were significant improvements in ISI, PSQI, MFIS, FSS, SOL, SSES, PHQ-9, and MSIS-29, but not SE, TST, or GAD-7. There were no significant differences between the F2F-CBTi group and tele-CBTi group for magnitude of change in the primary outcomes (ISI, PSQI, MFIS, and FSS) or the secondary outcomes (SOL, SE, TST, SSES, PHQ-9, GAD-7, and MSIS-29). Conclusions. Tele-CBTi is feasible and has outcome measures that are similar to that of in-person CBT-I treatment. Tele-CBTi may increase access to insomnia treatment in individuals with MS.
AbstractList Background. Over 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person cognitive behavioral therapy for insomnia (F2F-CBTi) is currently the first-line treatment for insomnia. However, given potential limitations to access including mobility difficulty, fatigue, or living in a rural area, telehealth-delivered CBT-I (tele-CBTi) has been considered as an alternative treatment. The purpose of this study was to assess the feasibility and treatment effect of tele-CBTi in people with MS and compare it to outcomes from a F2F-CBTi study in individuals with MS. Methods. 11 individuals with MS and symptoms of insomnia participated in 6 weekly CBT-I sessions with a trained CBT-I provider via live video. Insomnia severity (ISI), sleep quality (PSQI), and fatigue severity (FSS and MFIS) were assessed pre- and posttreatment as primary outcomes. Sleep onset latency (SOL), sleep efficiency (SE) and total sleep time (TST) from the PSQI, depression (PHQ-9), anxiety (GAD-7), sleep self-efficacy (SSES), and quality of life (MSIS-29) were also assessed pre- and posttreatment as secondary outcomes. Results. Participants resided in 9 different states. Retention and adherence rates were 100%. There were significant improvements in ISI, PSQI, MFIS, FSS, SOL, SSES, PHQ-9, and MSIS-29, but not SE, TST, or GAD-7. There were no significant differences between the F2F-CBTi group and tele-CBTi group for magnitude of change in the primary outcomes (ISI, PSQI, MFIS, and FSS) or the secondary outcomes (SOL, SE, TST, SSES, PHQ-9, GAD-7, and MSIS-29). Conclusions. Tele-CBTi is feasible and has outcome measures that are similar to that of in-person CBT-I treatment. Tele-CBTi may increase access to insomnia treatment in individuals with MS.
Over 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person cognitive behavioral therapy for insomnia (F2F-CBTi) is currently the first-line treatment for insomnia. However, given potential limitations to access including mobility difficulty, fatigue, or living in a rural area, telehealth-delivered CBT-I (tele-CBTi) has been considered as an alternative treatment. The purpose of this study was to assess the feasibility and treatment effect of tele-CBTi in people with MS and compare it to outcomes from a F2F-CBTi study in individuals with MS.BackgroundOver 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person cognitive behavioral therapy for insomnia (F2F-CBTi) is currently the first-line treatment for insomnia. However, given potential limitations to access including mobility difficulty, fatigue, or living in a rural area, telehealth-delivered CBT-I (tele-CBTi) has been considered as an alternative treatment. The purpose of this study was to assess the feasibility and treatment effect of tele-CBTi in people with MS and compare it to outcomes from a F2F-CBTi study in individuals with MS.11 individuals with MS and symptoms of insomnia participated in 6 weekly CBT-I sessions with a trained CBT-I provider via live video. Insomnia severity (ISI), sleep quality (PSQI), and fatigue severity (FSS and MFIS) were assessed pre- and posttreatment as primary outcomes. Sleep onset latency (SOL), sleep efficiency (SE) and total sleep time (TST) from the PSQI, depression (PHQ-9), anxiety (GAD-7), sleep self-efficacy (SSES), and quality of life (MSIS-29) were also assessed pre- and posttreatment as secondary outcomes.Methods11 individuals with MS and symptoms of insomnia participated in 6 weekly CBT-I sessions with a trained CBT-I provider via live video. Insomnia severity (ISI), sleep quality (PSQI), and fatigue severity (FSS and MFIS) were assessed pre- and posttreatment as primary outcomes. Sleep onset latency (SOL), sleep efficiency (SE) and total sleep time (TST) from the PSQI, depression (PHQ-9), anxiety (GAD-7), sleep self-efficacy (SSES), and quality of life (MSIS-29) were also assessed pre- and posttreatment as secondary outcomes.Participants resided in 9 different states. Retention and adherence rates were 100%. There were significant improvements in ISI, PSQI, MFIS, FSS, SOL, SSES, PHQ-9, and MSIS-29, but not SE, TST, or GAD-7. There were no significant differences between the F2F-CBTi group and tele-CBTi group for magnitude of change in the primary outcomes (ISI, PSQI, MFIS, and FSS) or the secondary outcomes (SOL, SE, TST, SSES, PHQ-9, GAD-7, and MSIS-29).ResultsParticipants resided in 9 different states. Retention and adherence rates were 100%. There were significant improvements in ISI, PSQI, MFIS, FSS, SOL, SSES, PHQ-9, and MSIS-29, but not SE, TST, or GAD-7. There were no significant differences between the F2F-CBTi group and tele-CBTi group for magnitude of change in the primary outcomes (ISI, PSQI, MFIS, and FSS) or the secondary outcomes (SOL, SE, TST, SSES, PHQ-9, GAD-7, and MSIS-29).Tele-CBTi is feasible and has outcome measures that are similar to that of in-person CBT-I treatment. Tele-CBTi may increase access to insomnia treatment in individuals with MS.ConclusionsTele-CBTi is feasible and has outcome measures that are similar to that of in-person CBT-I treatment. Tele-CBTi may increase access to insomnia treatment in individuals with MS.
Over 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person cognitive behavioral therapy for insomnia (F2F-CBTi) is currently the first-line treatment for insomnia. However, given potential limitations to access including mobility difficulty, fatigue, or living in a rural area, telehealth-delivered CBT-I (tele-CBTi) has been considered as an alternative treatment. The purpose of this study was to assess the feasibility and treatment effect of tele-CBTi in people with MS and compare it to outcomes from a F2F-CBTi study in individuals with MS. 11 individuals with MS and symptoms of insomnia participated in 6 weekly CBT-I sessions with a trained CBT-I provider via live video. Insomnia severity (ISI), sleep quality (PSQI), and fatigue severity (FSS and MFIS) were assessed pre- and posttreatment as primary outcomes. Sleep onset latency (SOL), sleep efficiency (SE) and total sleep time (TST) from the PSQI, depression (PHQ-9), anxiety (GAD-7), sleep self-efficacy (SSES), and quality of life (MSIS-29) were also assessed pre- and posttreatment as secondary outcomes. Participants resided in 9 different states. Retention and adherence rates were 100%. There were significant improvements in ISI, PSQI, MFIS, FSS, SOL, SSES, PHQ-9, and MSIS-29, but not SE, TST, or GAD-7. There were no significant differences between the F2F-CBTi group and tele-CBTi group for magnitude of change in the primary outcomes (ISI, PSQI, MFIS, and FSS) or the secondary outcomes (SOL, SE, TST, SSES, PHQ-9, GAD-7, and MSIS-29). Tele-CBTi is feasible and has outcome measures that are similar to that of in-person CBT-I treatment. Tele-CBTi may increase access to insomnia treatment in individuals with MS.
Audience Academic
Author Drerup, Michelle
Siengsukon, Catherine F.
Turkowitch, David
Nelson, Eryen
Ludwig, Rebecca
AuthorAffiliation 1 Department of Physical Therapy, Rehabilitation Science, And Athletic Training, University of Kansas Medical Center, Kansas City, KS, USA
2 Sleep Disorders Clinic, Cleveland Clinic, Cleveland, OH, USA
AuthorAffiliation_xml – name: 2 Sleep Disorders Clinic, Cleveland Clinic, Cleveland, OH, USA
– name: 1 Department of Physical Therapy, Rehabilitation Science, And Athletic Training, University of Kansas Medical Center, Kansas City, KS, USA
Author_xml – sequence: 1
  givenname: David
  surname: Turkowitch
  fullname: Turkowitch, David
  organization: Department of Physical TherapyRehabilitation ScienceAnd Athletic TrainingUniversity of Kansas Medical CenterKansas CityKSUSAkumc.edu
– sequence: 2
  givenname: Rebecca
  surname: Ludwig
  fullname: Ludwig, Rebecca
  organization: Department of Physical TherapyRehabilitation ScienceAnd Athletic TrainingUniversity of Kansas Medical CenterKansas CityKSUSAkumc.edu
– sequence: 3
  givenname: Eryen
  surname: Nelson
  fullname: Nelson, Eryen
  organization: Department of Physical TherapyRehabilitation ScienceAnd Athletic TrainingUniversity of Kansas Medical CenterKansas CityKSUSAkumc.edu
– sequence: 4
  givenname: Michelle
  surname: Drerup
  fullname: Drerup, Michelle
  organization: Sleep Disorders ClinicCleveland ClinicClevelandOHUSAclevelandclinic.org
– sequence: 5
  givenname: Catherine F.
  orcidid: 0000-0002-7706-6804
  surname: Siengsukon
  fullname: Siengsukon, Catherine F.
  organization: Department of Physical TherapyRehabilitation ScienceAnd Athletic TrainingUniversity of Kansas Medical CenterKansas CityKSUSAkumc.edu
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35281348$$D View this record in MEDLINE/PubMed
BookMark eNp9kl1vFCEUhiemxtbaO68NiYkx0W2BmeHDC5N1_WpSo0nXa8IwTOc0LGwHZpv-e1l3W7uNChcc4DkvHHifFns-eFsUzwk-JqSuTyim9IQTgmtBHxUHFEs8oYzRvbu4rvaLoxgvcW41plyUT4r9sqaClJU4KNLcOttb7VI_-WgdrOxgWzQLFx5SnqAPttcrCIN2aN7bQS9vUBcGdOpjWHjQCHyOW1hBO2oX0TWkHn0bXYKls-jcODuECPEdmqIf4EJC52lsb54Vj7tM26PteFj8_PxpPvs6Ofv-5XQ2PZuYirM0qTttZKlxJcqmKxsitaC0FUKSxoiqa3RNSck46SQRXEtZCd3wpsFGly0XpisPi_cb3eXYLGxrrE-5ELUcYKGHGxU0qN0dD726CCslJGaS8SzweiswhKvRxqQWEI11TnsbxqgoK4WsGOUsoy8foJdhHHwu7zdVV1xi-Ye60M4q8F3I55q1qJoyyRkrOVlrHf-Fyr21CzDZAR3k9Z2EV_cSNt8ZgxsTBB93wRf3X-TuKW4NkQG6AUz-uDjYThlIeq2TrwBOEazWxlNr46mt8XLS2wdJt7r_wN9s8B58q6_h__QvuSzjsg
CitedBy_id crossref_primary_10_1007_s00520_022_07378_8
crossref_primary_10_1007_s11682_024_00925_3
crossref_primary_10_7717_peerj_17491
Cites_doi 10.1159/000117070
10.7326/M14-2841
10.1177/1352458507078392
10.7224/1537-2073.2019-122
10.1212/wnl.45.2.251
10.1046/j.1525-1497.2001.016009606.x
10.1093/brain/124.5.962
10.1097/ALN.0b013e31816d83e4
10.1016/0165-1781(89)90047-4
10.1093/sleep/34.5.601
10.1177/1545968306298934
10.1001/jamainternmed.2015.3006
10.1185/03007990903167415
10.1016/j.sleep.2007.11.004
10.1016/j.jns.2011.07.015
10.1016/j.jbi.2008.08.010
10.1186/1471-2377-11-28
10.1093/sleep/zsaa136
10.1001/archneur.1989.00520460115022
10.1177/1352458508092807
10.1371/journal.pone.0149139
10.1159/000335379
10.1007/s11910-018-0809-7
10.1191/135248506ms1320oa
10.1016/j.sleep.2018.03.017
10.1093/sleep/32.12.1549
10.1093/sleep/zsab166
10.5665/sleep.6012
10.1016/j.dhjo.2017.04.011
10.1016/j.smrv.2014.06.010
10.1016/j.pain.2014.04.032
10.1186/1471-2296-13-40
10.1001/archneur.1992.00530300077013
10.1016/j.smrv.2017.01.006
10.1080/15402002.2016.1173551
10.1001/jamapsychiatry.2018.2745
10.1136/ebm.11.6.184
10.1016/j.msard.2020.101958
10.1136/aim.2009.000760
ContentType Journal Article
Copyright Copyright © 2022 David Turkowitch et al.
COPYRIGHT 2022 John Wiley & Sons, Inc.
Copyright © 2022 David Turkowitch et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright © 2022 David Turkowitch et al. 2022
Copyright_xml – notice: Copyright © 2022 David Turkowitch et al.
– notice: COPYRIGHT 2022 John Wiley & Sons, Inc.
– notice: Copyright © 2022 David Turkowitch et al. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Copyright © 2022 David Turkowitch et al. 2022
DBID RHU
RHW
RHX
AAYXX
CITATION
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
COVID
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOI 10.1155/2022/7110582
DatabaseName Hindawi Publishing Complete
Hindawi Publishing Subscription Journals
Hindawi Publishing Open Access
CrossRef
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni Edition)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
Coronavirus Research Database
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
Coronavirus Research Database
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef

PubMed
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: RHX
  name: Hindawi Publishing Open Access
  url: http://www.hindawi.com/journals/
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2090-2662
Editor Arnett, Peter
Editor_xml – sequence: 1
  givenname: Peter
  surname: Arnett
  fullname: Arnett, Peter
EndPage 8
ExternalDocumentID PMC8906967
A697663716
35281348
10_1155_2022_7110582
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: National Institutes of Health Clinical and Translational Science Award
  grantid: UL1 TR002366
– fundername: NCATS NIH HHS
  grantid: UL1 TR002366
GroupedDBID ---
188
4.4
53G
5VS
7X7
8FI
8FJ
AAFWJ
AAJEY
ABDBF
ABUWG
ADBBV
ADRAZ
AFKRA
AFPKN
AINHJ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
CCPQU
EBD
EBS
ESX
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IEA
IHR
IHW
ITC
KQ8
M48
M~E
OK1
PIMPY
RHU
RHW
RHX
RNS
RPM
TUS
UKHRP
0R~
24P
AAMMB
AAYXX
ACCMX
ACUHS
AEFGJ
AFFHD
AGXDD
AIDQK
AIDYY
ALUQN
CITATION
H13
PGMZT
PHGZM
PHGZT
2UF
ALIPV
CEFSP
CNMHZ
EJD
IL9
NPM
UZ5
3V.
7XB
8FK
AZQEC
COVID
DWQXO
K9.
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
ID FETCH-LOGICAL-c476t-5fac93a0483bf3b19a822d8891bc84fba5213671f9187a9948ab7bb0ca3d78cf3
IEDL.DBID BENPR
ISICitedReferencesCount 10
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000778348100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2090-2654
IngestDate Tue Nov 04 02:01:54 EST 2025
Sun Nov 09 09:36:52 EST 2025
Tue Oct 07 07:21:07 EDT 2025
Tue Nov 11 10:55:45 EST 2025
Tue Nov 04 18:14:08 EST 2025
Thu May 22 21:26:53 EDT 2025
Wed Feb 19 02:05:10 EST 2025
Sat Nov 29 02:54:09 EST 2025
Tue Nov 18 22:16:03 EST 2025
Sun Jun 02 19:22:09 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
https://creativecommons.org/licenses/by/4.0
Copyright © 2022 David Turkowitch et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c476t-5fac93a0483bf3b19a822d8891bc84fba5213671f9187a9948ab7bb0ca3d78cf3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Academic Editor: Peter Arnett
ORCID 0000-0002-7706-6804
OpenAccessLink https://www.proquest.com/docview/2638547909?pq-origsite=%requestingapplication%
PMID 35281348
PQID 2638547909
PQPubID 4727247
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8906967
proquest_miscellaneous_2638946276
proquest_journals_2638547909
gale_infotracmisc_A697663716
gale_infotracacademiconefile_A697663716
gale_healthsolutions_A697663716
pubmed_primary_35281348
crossref_citationtrail_10_1155_2022_7110582
crossref_primary_10_1155_2022_7110582
hindawi_primary_10_1155_2022_7110582
PublicationCentury 2000
PublicationDate 2022-03-02
PublicationDateYYYYMMDD 2022-03-02
PublicationDate_xml – month: 03
  year: 2022
  text: 2022-03-02
  day: 02
PublicationDecade 2020
PublicationPlace Egypt
PublicationPlace_xml – name: Egypt
– name: New York
PublicationTitle Multiple sclerosis international
PublicationTitleAlternate Mult Scler Int
PublicationYear 2022
Publisher Hindawi
John Wiley & Sons, Inc
Publisher_xml – name: Hindawi
– name: John Wiley & Sons, Inc
References 22
44
23
45
24
Pew Research Center (43) 2021
25
26
27
29
P. G. Ritvo (28) 1997
30
10
32
11
12
34
13
35
14
36
15
37
16
38
17
39
18
19
1
M. L. Perlis (33) 2005
P. Lacks (31) 1987
3
4
5
6
P. A. Calabresi (2) 2004; 70
7
8
A. Perrin (42) 2021
9
40
41
20
21
References_xml – ident: 5
  doi: 10.1159/000117070
– ident: 16
  doi: 10.7326/M14-2841
– ident: 36
  doi: 10.1177/1352458507078392
– volume-title: Psychology Practitioner Guidebooks
  year: 1987
  ident: 31
  article-title: Behavioral Treatment for Persistent Insomnia
– ident: 20
  doi: 10.7224/1537-2073.2019-122
– ident: 21
  doi: 10.1212/wnl.45.2.251
– ident: 25
  doi: 10.1046/j.1525-1497.2001.016009606.x
– volume-title: Msqli: multiple sclerosis quality of life inventory: a user’s manual
  year: 1997
  ident: 28
– ident: 32
  doi: 10.1093/brain/124.5.962
– ident: 23
  doi: 10.1097/ALN.0b013e31816d83e4
– ident: 26
  doi: 10.1016/0165-1781(89)90047-4
– ident: 22
  doi: 10.1093/sleep/34.5.601
– ident: 1
  doi: 10.1177/1545968306298934
– ident: 12
  doi: 10.1001/jamainternmed.2015.3006
– ident: 34
  doi: 10.1185/03007990903167415
– ident: 10
  doi: 10.1016/j.sleep.2007.11.004
– ident: 7
  doi: 10.1016/j.jns.2011.07.015
– ident: 29
  doi: 10.1016/j.jbi.2008.08.010
– ident: 24
  doi: 10.1186/1471-2377-11-28
– ident: 17
  doi: 10.1093/sleep/zsaa136
– volume-title: About three-in-ten U.S. adults say they are ‘almost constantly’ online
  year: 2021
  ident: 42
– ident: 27
  doi: 10.1001/archneur.1989.00520460115022
– ident: 3
  doi: 10.1177/1352458508092807
– ident: 15
  doi: 10.1371/journal.pone.0149139
– ident: 37
  doi: 10.1159/000335379
– ident: 9
  doi: 10.1007/s11910-018-0809-7
– ident: 4
  doi: 10.1191/135248506ms1320oa
– ident: 13
  doi: 10.1016/j.sleep.2018.03.017
– ident: 44
  doi: 10.1093/sleep/32.12.1549
– ident: 45
  doi: 10.1093/sleep/zsab166
– volume: 70
  start-page: 1935
  issue: 10
  year: 2004
  ident: 2
  article-title: Diagnosis and management of multiple sclerosis
  publication-title: American family physician
– ident: 6
  doi: 10.5665/sleep.6012
– ident: 11
  doi: 10.1016/j.dhjo.2017.04.011
– ident: 40
  doi: 10.1016/j.smrv.2014.06.010
– ident: 41
  doi: 10.1016/j.pain.2014.04.032
– ident: 14
  doi: 10.1186/1471-2296-13-40
– ident: 8
  doi: 10.1001/archneur.1992.00530300077013
– ident: 38
  doi: 10.1016/j.smrv.2017.01.006
– volume-title: Internet/Broadband Fact Sheet
  year: 2021
  ident: 43
– ident: 19
  doi: 10.1080/15402002.2016.1173551
– volume-title: Cognitive Behavioral Treatment of Insomnia: A Session-by-Session Guide
  year: 2005
  ident: 33
– ident: 39
  doi: 10.1001/jamapsychiatry.2018.2745
– ident: 30
  doi: 10.1136/ebm.11.6.184
– ident: 18
  doi: 10.1016/j.msard.2020.101958
– ident: 35
  doi: 10.1136/aim.2009.000760
SSID ssj0000502783
Score 2.2442632
Snippet Background. Over 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person...
Over 50% of individuals with multiple sclerosis (MS) have moderate or severe sleep disturbances, insomnia being the most common. In-person cognitive behavioral...
SourceID pubmedcentral
proquest
gale
pubmed
crossref
hindawi
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1
SubjectTerms Anxiety
Behavior modification
Behavioral health care
Care and treatment
Cognitive behavioral therapy
Cognitive therapy
Fatigue
Insomnia
Multiple sclerosis
Nervous system
Quality of life
Questionnaires
Restless legs syndrome
Retention
Sleep disorders
Standard deviation
Telemedicine
SummonAdditionalLinks – databaseName: Hindawi Publishing Open Access
  dbid: RHX
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3di9QwEA96KAgifltdNcKJD1LsRz59W0-PE_Q4dJV9K0macoW97nHtKf73zrRpsaeiL6Ul007azGRmkplfCdn10nGrXBYzn8PBqjI2RrOYiTKreMl11eMWfP0gDw_Veq2PAkhS-_sWPlg7DM-zVxLMFFcw115WHIX308F6WkpJOG6f4V5ylugkzgRnY4r7hdtnxidMwVePMfj9Xv_JxbyYKfmL6dm_SW4En5Euh0G-RS755ja5Piy40aGO6A7pVmBAhqrG-K3fYLqFL-nemB1E30z1-HQ1IAlQ8Ffp-6bdnjS1oXUD52NxVktxfZZ-DNmG9DPwhTeq29d0SY_qzbajmID44y75sv9utXcQh18qxI5J0cW8Mk7nBnHkbZXbVBtwEEqldGqdYpU1YM1zIdNKp0oarZkyVlqbOJOXUrkqv0d2mm3jHxDqTQrPVDABlJ5x5Y1NwFNXlZCygjAui8jL8VsXLuCN428vNkUfd3Be4MgUYWQi8nyiPh1wNv5C9xSHrRi-56SexVKAXyVyiP4i8qKnQAUFfs6EOgPoNUJdzSgXM0pQLDdr3g2i8Y8eLUa5KYL-t0UG0xpnUic6Is-mZmSAOW2N354PNJqJTAKn-4OYTYwQcyfNmYqInAngRICo4POWpj7u0cGVToQW8uH_9f4RuYaXfVZdtiA73dm5f0yuuG9d3Z496fXsJ2mWH9c
  priority: 102
  providerName: Hindawi Publishing
Title Telehealth-Delivered Cognitive Behavioral Therapy for Insomnia in Individuals with Multiple Sclerosis: A Pilot Study
URI https://dx.doi.org/10.1155/2022/7110582
https://www.ncbi.nlm.nih.gov/pubmed/35281348
https://www.proquest.com/docview/2638547909
https://www.proquest.com/docview/2638946276
https://pubmed.ncbi.nlm.nih.gov/PMC8906967
Volume 2022
WOSCitedRecordID wos000778348100001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2090-2662
  dateEnd: 20240131
  omitProxy: false
  ssIdentifier: ssj0000502783
  issn: 2090-2654
  databaseCode: 7X7
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2090-2662
  dateEnd: 20240131
  omitProxy: false
  ssIdentifier: ssj0000502783
  issn: 2090-2654
  databaseCode: BENPR
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2090-2662
  dateEnd: 20240131
  omitProxy: false
  ssIdentifier: ssj0000502783
  issn: 2090-2654
  databaseCode: PIMPY
  dateStart: 20130101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 2090-2662
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000502783
  issn: 2090-2654
  databaseCode: 24P
  dateStart: 20100101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELdYBxIS4vujUIaRhnhA0fJhxzYvqBubNolV1Sioe4ocx9EilWQsHYj_nrvECQTx8cBLGtWnnBOfz3fnu58J2bbC8FSa0GM2gksqM09rxTwWZ2HOM67yBrfg4zsxm8nlUs1dwK12aZWdTmwUdVYZjJHvhCAonAnlqzfnnz08NQp3V90RGhtkE5HK2Ihs7u7P5id9lMXnuLOG28yhr3wvjDnrst85R8c_3BGwAHIZDtYlp52vnaFf_LX4nfX5axLlT6vSwa3_fZ_b5KazR-m0FaA75Iot75IbbTCPtjVK98h6AYtTWzHpvbUrTOWwGd3rMo_obl_rTxctSgEFW5gelXX1qSw0LUq47wq_aoqxX3rsMhnpe-ALn6SoX9MpnRerak0xufHbffLhYH-xd-i54xo8w0S89niujYo0YtSneZQGSoPxkUmpgtRIlqcaLIUoFkGuAim0UkzqVKSpb3SUCWny6AEZlVVpHxFqdQDPlKBcMsu4tDr1wQuQeSxEDi5iOCavusFKjMMyxyM1Vknj03Ce4NAmbmjH5EVPfd5iePyB7hmOe9J-z37qJ9MYbLY4As9yTF42FDj5gZ_RroYBeo0wWgPKyYASJq0ZNG872fpHjyad8CROt9TJD8kZk-d9MzLAfLnSVpctjWJxKIDTw1ZOe0aI5xNETI6JGEhwT4CI48OWsjhrkMel8mMVi8d_79YTch1fosnUCydktL64tE_JVfNlXdQXW2RDLEVzlVtuusLv_Oh4fgr_nhwuvwOhKEa-
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELbKFgQS4v0ILNRIrTigqIljxzYSQktL1VV3VyuxoHIKjuOokZakNFuq_il-I-O8IIjHqQcuUSSPYif5POMZz3xGaNNwzWKhiUtNAJdYJK5Skro0TEjKEibTirfgw4TPZuLwUM7X0Le2FsamVbY6sVLUSaFtjHybAFAY5dKTr4-_uPbUKLu72h6hUcPiwJyfgctWvhrvwv_dImTv7WJn321OFXA15eHKZanSMlCWSj1Og9iXCmxkIoT0Yy1oGiswaEHI_VT6gispqVAxj2NPqyDhQqcBPPcSWqcAdjFA6_PxdP6xi-p4zO7k2W1t4knPJSGjbbY9YzbQQLY5GFwmSM8ONtbgypH1w8-y3612f03a_MkK7t38377fLXSjWW_jUT1BbqM1k99B1-tgJa5rsO6i1QKMb10R6u6apU1VMQneaTOr8JuOywAvahYGDGt9PM7L4nOeKZzlcN8WtpXYxrbxtMnUxO-gX_gFWfkSj_A8WxYrbJM3z--h9xfy4vfRIC9y8xBho3x4pgDlmRjKhFGxB16OSEPOU3CBiYNetOCIdMPVbo8MWUaVz8ZYZKEUNVBy0FYnfVxzlPxBbsPiLKq_Z6faolEIa9IwAM_ZQc8rCavcoD-tmhoNGLWlCetJDnuSoJR0r3mzwfI_RjRswRo1urOMfiDVQc-6ZtuBzQfMTXFay0gaEg49PajnRdeR5SvyAyocxHszphOwjOr9ljw7qpjVhfRCGfJHfx_WBrq6v5hOosl4dvAYXbMvVGUlkiEarE5OzRN0WX9dZeXJ00Y9YPTpomfUd0JEn7Y
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3db9MwELfGBggJ8f1RKMxIm3hAURPHjm0khMpKRbWtqkSHxlNwHEeLVNKxdEz71_jrOCdOIIiPpz3wEkXyKeck9-E7_-6M0JbhmiVCE4-aEC6JSD2lJPVolJKMpUxmVd-CD3t8OhWHh3K2hr41tTAWVtnYxMpQp0ttc-QDAoLCKJe-HGQOFjEbjV8ff_HsCVJ2p7U5TqMWkV1zfgbhW_lqMoJ_vU3I-O18553nThjwNOXRymOZ0jJUtq16koVJIBX4y1QIGSRa0CxR4NzCiAeZDARXUlKhEp4kvlZhyoXOQnjuJbQBS3IKOrYxm-zPPrYZHp_ZXT27xU186XskYrRB3jNmkw5kwMH5MkE6PtF5hitHNiY_y3-38v0VwPmTRxzf_J-_5S10w63D8bBWnNtozRR30PU6iYnr2qy7aDUHp1xXinojs7AQFpPinQZxhd-0PQ7wvO7OgCEGwJOiXH4ucoXzAu6bgrcS25w33ncITvwe-MLvyMuXeIhn-WK5whbUeX4PHVzIi99H68WyMA8RNiqAZwowqqmhTBiV-BD9iCziPIPQmPTQi0ZQYu16uNujRBZxFcsxFluxip1Y9dB2S31c9y75A92mlbm4_p6tyYuHEaxVoxAi6h56XlFYowf8tHK1GzBr2z6sQ9nvUIKx0p3hLSfX_5hRvxHc2NnUMv4htT30rB22DCxOsDDL05pG0ohw4PSg1pGWke1jFIRU9BDvaE9LYDutd0eK_KjquC6kH8mIP_r7tDbRVVCjeG8y3X2Mrtn3qcCKpI_WVyen5gm6rL-u8vLkqbMUGH26aIX6DljaqHY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Telehealth-Delivered+Cognitive+Behavioral+Therapy+for+Insomnia+in+Individuals+with+Multiple+Sclerosis%3A+A+Pilot+Study&rft.jtitle=Multiple+sclerosis+international&rft.au=Turkowitch%2C+David&rft.au=Ludwig%2C+Rebecca&rft.au=Nelson%2C+Eryen&rft.au=Drerup%2C+Michelle&rft.date=2022-03-02&rft.issn=2090-2654&rft.eissn=2090-2662&rft.volume=2022&rft.spage=1&rft.epage=8&rft_id=info:doi/10.1155%2F2022%2F7110582&rft.externalDBID=n%2Fa&rft.externalDocID=10_1155_2022_7110582
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2090-2654&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2090-2654&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2090-2654&client=summon